120 related articles for article (PubMed ID: 36523200)
1. Comparing the safety and efficacy of intravenous naloxone administration in opioid-naive and opioid-tolerant hospitalized oncology patients.
Lee S; Tatla V; Buga S; Pon D
J Opioid Manag; 2022; 18(6):497-502. PubMed ID: 36523200
[TBL] [Abstract][Full Text] [Related]
2. Acute Opioid Withdrawal Following Intramuscular Administration of Naloxone 1.6 mg: A Prospective Out-Of-Hospital Series.
Isoardi KZ; Parker L; Harris K; Rashford S; Isbister GK
Ann Emerg Med; 2022 Aug; 80(2):120-126. PubMed ID: 35491292
[TBL] [Abstract][Full Text] [Related]
3. Postoperative analgesia after radical prostatectomy with high-dose intrathecal morphine and intravenous naloxone: a retrospective review.
Rebel A; Sloan P; Andrykowski M
J Opioid Manag; 2009; 5(6):331-9. PubMed ID: 20073407
[TBL] [Abstract][Full Text] [Related]
4. Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort study.
Purssell R; Godwin J; Moe J; Buxton J; Crabtree A; Kestler A; DeWitt C; Scheuermeyer F; Erdelyi S; Balshaw R; Rowe A; Cochrane CK; Ng B; Jiang A; Risi A; Ho V; Brubacher JR
Clin Toxicol (Phila); 2021 Jan; 59(1):38-46. PubMed ID: 32401548
[TBL] [Abstract][Full Text] [Related]
5. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty.
Patanwala AE; Jarzyna DL; Miller MD; Erstad BL
Pharmacotherapy; 2008 Dec; 28(12):1453-60. PubMed ID: 19025426
[TBL] [Abstract][Full Text] [Related]
6. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer.
Sykes NP
Palliat Med; 1996 Apr; 10(2):135-44. PubMed ID: 8800821
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the appropriateness of naloxone administration to patients receiving long-term opioid therapy.
Facey C; Brooks D; Boland JW
Hosp Pract (1995); 2016; 44(2):86-91. PubMed ID: 26837434
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of high-dose intrathecal morphine for analgesia after pelvic surgery.
Rebel A; Sloan P; Andrykowski M
Pain Res Manag; 2011; 16(1):19-26. PubMed ID: 21369537
[TBL] [Abstract][Full Text] [Related]
9. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.
Abdelal R; Raja Banerjee A; Carlberg-Racich S; Darwaza N; Ito D; Shoaff J; Epstein J
Harm Reduct J; 2022 May; 19(1):49. PubMed ID: 35596213
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent naloxone-induced morphine withdrawal symptoms in opioid-dependent males-a double-blinded, randomized study.
Weisshaar S; Brandt L; Litschauer B; Sheik-Rezaei S; Moser L; Nirnberger G; Kühberger E; Bauer U; Firbas C; Gouya G; Wolzt M; Fischer G
Br J Clin Pharmacol; 2020 Aug; 86(8):1610-1619. PubMed ID: 32145041
[TBL] [Abstract][Full Text] [Related]
11. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
12. New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.
Sanders M; Jones S; Löwenstein O; Jansen JP; Miles H; Simpson K
Pain Med; 2015 Aug; 16(8):1540-50. PubMed ID: 26110375
[TBL] [Abstract][Full Text] [Related]
13. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
14. Comment on Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens.
Jefri MY; Nelson LS
Clin Toxicol (Phila); 2021 Jan; 59(1):79-80. PubMed ID: 33156706
[No Abstract] [Full Text] [Related]
15. Acute pain management in opioid-tolerant patients: a growing challenge.
Huxtable CA; Roberts LJ; Somogyi AA; MacIntyre PE
Anaesth Intensive Care; 2011 Sep; 39(5):804-23. PubMed ID: 21970125
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.
Zamani N; Buckley NA; Hassanian-Moghaddam H
Crit Care; 2020 Feb; 24(1):44. PubMed ID: 32033582
[TBL] [Abstract][Full Text] [Related]
17. Safety, Efficacy, and Cost of 0.4-mg Versus 2-mg Intranasal Naloxone for Treatment of Prehospital Opioid Overdose.
Thompson J; Salter J; Bui P; Herbert L; Mills D; Wagner D; Brent C
Ann Pharmacother; 2022 Mar; 56(3):285-289. PubMed ID: 34229467
[TBL] [Abstract][Full Text] [Related]
18. Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers.
Walsh SL; Nuzzo PA; Babalonis S; Casselton V; Lofwall MR
Drug Alcohol Depend; 2016 May; 162():190-8. PubMed ID: 27012435
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
[TBL] [Abstract][Full Text] [Related]
20. Authors' reply to Comment on Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens.
Purssell R; Godwin J; Moe J; Buxton J; Kestler A; Brubacher JR
Clin Toxicol (Phila); 2021 Jan; 59(1):80-81. PubMed ID: 33215939
[No Abstract] [Full Text] [Related]
[Next] [New Search]
